Benzinga | Aug 4, 2020 04:04PM EDT

Evolent Health Q2 EPS $(0.03) Beats $(0.10) Estimate, Sales $238.60M Miss $241.03M Estimate

Evolent Health (NYSE:EVH) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.10) by 70 percent. This is a 88.46 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $238.60 million which missed the analyst consensus estimate of $241.03 million by 1.01 percent. This is a 24.19 percent increase over sales of $192.12 million the same period last year.